THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE
REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF
THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS
AMENDED
Creightons
plc
Unaudited interim financial
report
for the six months ended 30
September 2024
Financial highlights
· Improved Gross profit margin of 1.8% to 44.0% (2023: 42.2%)
on lower revenue for the first half of the financial year of £27.1m
(2023: £27.6m) as a result of cost reduction and SKU
rationalisation.
· The
operating profit before exceptional
costs increased to £1.7m (2023: £0.5m).
Operating profit before exceptional costs as a percentage of sales
increased to 6.3% (2023: 1.8%).
· EBITDA (excluding exceptional) for the first half of the
financial year 2024 was £2.5m (2023: £1.4m).
· Diluted EPS was 1.61p (2023: 0.37p).
· Net
cash on hand (cash and cash equivalents less short-term element of
obligations under finance leases and borrowings) were £1.5m (2023:
negative £1.7m). Net debt for the Group has reduced to £1.2m (2023:
£5.5m).
Operational highlights
· Private label saw growth in revenue whilst Branded and
Contract sales experienced a downturn in revenue
o Private label revenue (retailer own label products) increased
by 17.4% to £14.4m (2023: £12.3m).
o Branded revenue has decreased by 15.0% to £8.9m (2023:
£10.4m).
o Contract manufacturing revenue decreased by 21.5% to £3.8m
(2023: £4.9m).
· The
increase in selling prices to customers last year has positively
impacted this interim period, as evidenced by the improvement in
gross margin
o Sales teams continue to monitor Cost Price Increase (C.P.I)
across all categories of supply. This was used as the basis to
negotiate sales price increases with customers.
· Reduction in overheads
o Cost rationalisation as well as the integration of the Emma
Hardie subsidiary into the Group has seen administrative costs
decreased by 4.8% to £8.8m (2023: £9.3m).
· Benefits of the relocation of the customer facing aspect of,
warehousing, picking and packing and logistics back to the
Peterborough site are now being fully realised.
o Distribution costs have decreased by 25.3% to £1.4m (2023:
£1.9m).
· Reduction in stock levels
o We achieved stock reductions of £1.7m to £8.7m (2023:
£10.4m), without any reduction in effective service levels to
customers. Stock continues to be at lower levels than previous
years.
Managing Director's Statement
An
Improving Picture
During this period, we have achieved
the objective of establishing a strong fundamentals focused
strategy to secure the foundations with which to move forward and
create a sustainable, stable, profitable, and growing business.
Key achievements have been made in
private label sales growth, gross profit margin improvement,
continued overhead and stock reduction compared to September 2023
and positive cash control on a year-on-year basis which is driving
increased earnings per share for shareholders.
Whilst there is strong sales growth
in private label, contract manufacturing continues to slow, and the
market continues to be challenging for our brands. The
strategy of pursuing a multi revenue stream model and a broad
multi-category product offering continues to be a positive approach
for the business. This structure enables it to successfully
flex and adapt to meet both retailer and consumer demand.
The global personal care and beauty
markets continue to be dominated by customers seeking value and
trend driven products and brands. I believe we continue to be well
placed with our Quality, Service and Innovation approach to realise
growth opportunities. There remains additional market share
to be realised in the UK market coupled with a brand portfolio that
has international appeal, there are more market and channel
opportunities on which we can build.
Revenue Stream Performance
Private Label
Private label sales have increased
sales by 17.4% to £14.4m (2023: £12.3m) as consumers and retail
customers continue to seek performance products at value
prices.
This additional growth has been
fuelled by a number of factors:
· the
addition of two new UK retailers - both key target
achievements
· the
speed of launch to market driven by three key
customers
· exceptional consumer focussed product development by our
research and development (R&D) teams
· continued category and market expertise, frequently guiding
retailers on product ranges, strategies and consumer
positioning
· a
fully resourced private label team in both sales and product
management roles.
This is in addition to a good solid
performance across the customer base resulting in sales growth.
Creightons continues to be a leading supplier in the UK for private
label supply achieved through exceptional product development,
quality manufacturing and both consistency and speed of supply.
This position is achieved via the
Groups' ability to develop products that deliver relevant, consumer
focussed performance all whilst successfully managing customer
forecasts, stock and service levels into a demanding mass retailer
customer base.
Contract Manufacturing
Conversely, contract manufacturing
sales have continued to experience a downturn during the period of
21.5% to £3.8m (2023: £4.9m). This was anticipated in light of the
impact last year of reducing order books due to declining consumer
demand, overstocking and issues obtaining credit insurance.
All factors have continued to impact into this first
half.
The competitor profile in the
transactional supply segment offers very low-cost pricing that
doesn't meet our desired returns. As a result, this revenue stream
has not been a priority. Instead, resources were focused on the
private label channel, which has proven more successful, as
reflected in its growth.
Opportunities within this revenue
category needs to add value to the overall business, primarily in
terms of margin contribution, therefore, any opportunities are
given rigorous consideration. Development with existing customers
is ongoing and a number of new potential sales opportunities are
under review.
Brands
Brand performance in the first half
has been challenging and overall has seen a reduction of 15.0% to
£8.9m (2023: £10.4m).
A number of factors have
impacted:
· The
deliberate exit of poor margin performing products during the past
18 months has contributed to the decline in product listings in the
UK discounters. This is fuelled by the ongoing 'dupe' (an
affordable product match to a luxury benchmark) trend which is
taking increased shelf space. This has resulted in
significantly reduced opportunities to launch new product
development (NPD) in our core Creightons brand. Our haircare
offering has witnessed the most significant decline although with
product lines which were low margin performers. New NPD and
positioned products in the category will be launched during
2025.
· Poor
performance by a number of key distributors in international
markets. This has included the cessation of two distributors that
have broken contract terms. This has impacted Balance Active
Formula performance in the main.
· A
sizable international retail customer in the discount space has
pivoted into 'dupe' and 'fast follow' products, resulting in a
decline in brand NPD opportunities in the period. Recent
positive meetings with their senior team have presented
opportunities to return to growth into 2025 with more creative
product and buying strategies on current brand listings, and
opportunities for exclusive brand development.
Despite the challenges, there are
positive gains in brand which are central to moving growth
forward. UK Grocery and High Street are delivering
gains.
· Tzone: continues to perform well across the market, with new
listings and NPD coming during 2025.
· Feather and Down: the main UK listing is in growth and the
brand has launched into its first international market, Spinneys in
UAE. Additional shelf space and stores in the UK market are
planned into 2025.
· The
Curl Company: continues to grow in both the UK and its
current international direct to retail markets. NPD planned
for 2025 in all markets and to drive new listings.
· Balance Active Formula: despite the international challenges,
is performing in UK retailers, specifically within grocery.
Meaningful discussions with another grocery listing
underway.
· Emma
Hardie has witnessed growth in the UK market since the purchase of
the brand in July 2021 (more detail below).
Sales growth and margin maintenance
are the priorities moving forward. The focus with current
customers, UK and international, is on increasing the number of
outlets stocking Group branded product and increasing footprint in
each store. Gaining more space, and more products driven by
NPD, in more stores is the goal. We also need to build on our
direct to retail international business with new customers in
additional markets to de-risk global expansion.
Emma Hardie
A more focused and integrated team
approach over the first half of this year has resulted in growth in
UK sales for the brand. The brand is now making a positive
contribution to the Group.
The revised sales strategy outlined
previously remains central to growing the brand. This
includes:
· Expansion into the international market, China: Relaunch of
sales activities on digital platforms will commence in early 2025
with a revised to market model.
· Digital: ongoing and increased investment across Amazon,
third party pure players and Emmahardie.com continues to be a
priority channel.
· Travel Sector: the initial trial launch of the brand
into the UK's duty-free travel sector is yielding positive results.
This success is helping to create a more tailored travel product
offering, with plans to continue testing and expanding this
channel.
· UK
Offline: key retail listings in the UK channel remain the core
sales driver of the brand with Marks & Spencer performing well
and meaningful discussions underway with two potential new listings
during 2025.
The brand benefits from an
exceptionally loyal and repeat purchase customer base here in the
UK. This is coupled with significant industry awareness and
recognition which is a testament to its superior product
performance. The key developmental objective is to build
wider consumer awareness of the brand. Additional listings in
the UK market, extending the digital footprint and expanding the
travel channel will be key steps in achieving this.
Research and Development
Central to our success and strategy,
the team continues to grow in both skills and performance.
Year-to-date, we have achieved two significant successes, alongside
ongoing focused developments in skincare NPD. There has been a
significant increase in pace required by the market for product
launches and NPD. Our R&D team has delivered on ensuring we can
realise the opportunities presented by stepping up skill sets and
increasing speed of product diversity, innovation and products that
consumers want here and now. This has been key in the reported
private label growth.
SPF skincare developments continue to progress and will result in
our first branded SPF skincare products launching in early 2025, in
Balance Active Formula and TZone brands. Private label and some
existing contract customer opportunities within this category of
product are also being progressed.
As the consumer continues to demand
more performance skincare for a wider range of solutions and needs,
we continue to invest in textures, ingredient performance and new
technologies.
Moving into the second half of 2025
and beyond, a re-focus on haircare NPD will feature as an area for
both private label and branded revenue streams.
Manufacturing and Operations
Production
This period has seen a continuing
improvement in production efficiencies which has contributed to the
overall gross profit margin improvements being reported.
There are a number of areas driving this:
· A
continual review of the output of each production line; working
methodically through both speed and technical
bottlenecks.
· Investing in areas to increase capacity and reduce labour
cost or utilise resource more efficiently.
· Implementing an enhanced grading scheme for operational staff
and investing in upskilling.
· Ongoing drive to reduce change over times and
downtime.
As we move forward teams are working
on reviewing IT solutions, including AI, across the whole operation
to reduce administration, increase output and reduce labour
intensive operations. This will be a continual and ongoing
investment area.
Logistics
The benefits of significantly
reducing reliance on a 3PL for warehousing in the past year
continues to deliver both efficiency and cost benefits. This
includes investing to build a more multi-skilled and flexible
team. Distribution gains have also been made in the transfer
of goods between the two sites through improved planning, extended
visibility and eliminating inefficiency where evident.
Procurement
Purchasing continues to be focused
on delivering gains where possible and working on ensuring the
reduction in inflationary pressures flow through to reducing
costs. Some headwinds in specific raw material supplies are
anticipated into early 2025 where environmental issues or
legislation are impacting upon supply. We are looking forward
where possible to mitigate and identify additional sources in order
to keep any impact to a minimum.
Team Development
I am pleased to report that we have
made significant progress in recruiting industry experienced
skilled staff to fill vacancies over the past six months,
particularly within the private label sales team and senior branded
sales positions. This will help us drive for and deliver new sales
listings.
The senior management team continues
to grow and deliver on the continuous improvements required to
support the growth plans.
Summary and Outlook
I am pleased with the notable
improved performance for this trading period and commend the wider
team on delivering the objectives we set earlier in the year to
remain focused on stabilising the core business.
The next 6 - 12 months will see more
new product development being delivered to support private label
sales growth, but also to reverse brands which have declined in a
focussed drive back to growth. This will include a number of
exclusive brand extensions with key retail partners in order to
compete with 'dupe' product offerings, alongside strategic new
developments for long term brand growth. We continue to
ensure consumer insight and data is at the core of development to
help deliver the best outcomes of success.
There will always be ongoing
challenges facing any business. Our trading history demonstrates
that as a team we have always been flexible and adept at meeting
these challenges. The Group calculates that the annual impact
of the budget announcements will total £0.6m, with increased NI
costs of £0.4m, and the increase in the national minimum wage of
£0.2m. There will also be an additional impact on pay differentials
that will need to be managed. The management team are in the
process of identifying and implementing detailed plans to mitigate
the impact. This will include the need to re-negotiate prices with
our customers where possible, product re-engineering, reviews of
working practices to streamline processes, including utilising
technology and key operational investments, where appropriate.
Creightons is a multi-revenue stream
business that at its core demonstrates agility and flexibility
along with market and product expertise to meet and exceed the
demands of a constantly evolving market and consumer. Our
strength in the private label supply channel is evident in the
enviable customer base we supply and our strategic retail
partnerships.
We have embarked upon a strategic
review of our market, sales and brand development strategy to
ensure that we can deliver above trend sales growth across all
areas of our business.
Strength in private label supply,
creativity in brand development and robust service to the market
presents opportunities to expand the business as we move into
2025/2026.
Finally, I would like to thank our
valued team of employees, customers, suppliers and all stakeholders
for their continued support.
Philippa Clark
Group Managing Director
Financial overview
Revenue
Revenue for Private label increased to £14.4m (2023: £12.3m), Branded
revenue reduced to £8.9m (2023: £10.4m), and Contract revenue
reduced to £3.8m (2023: £4.9m).
|
Six months
ended
30 September
2024
(Unaudited)
|
Six months
ended
30 September 2023
(Unaudited)
|
Movement vs Same Period Last
Financial Year
|
|
% Change vs Same Period Last
Financial Year
|
|
£000
|
£000
|
£000
|
|
|
Branded
|
8,851
|
10,417
|
(1,566)
|
|
(15.0)%
|
Private
label
|
14,395
|
12,259
|
2,136
|
|
17.4%
|
Contract
|
3,822
|
4,868
|
(1,046)
|
|
(21.5)%
|
Other
|
10
|
11
|
(1)
|
|
(9.1)%
|
|
|
|
|
|
|
Net sales
|
27,078
|
27,555
|
(477)
|
|
(1.7)%
|
Revenue is generated from three
main revenue streams, Branded, Private label and Contract. Each of
these revenue streams are reported in the statutory accounts are
net of deductions. These sales related deductions consist of
Contracted retailer support, Settlement discounts, and Retailer
promotions. These activities are sales related activities that help
generate additional revenue for the business.
Branded sales have experienced a
reduction in revenue largely due to the Group's strategy of
rationalising SKU's that do not achieve a commercially viable
contribution margin. Additionally, increased competition from
"dupes" (an affordable product match to a luxury benchmark), in the
discount sector has resulted in a decline in U.K. sales and poor
performing distributors in selected international
markets.
Contract sales continue to be
challenged through contract customers being overstocked and the
inability to obtain credit insurance.
Private label has seen significant
growth as a result of new customer wins, and our dominance in the
market of being highly innovative, increasing pace of NPD delivery
and exceptional quality and strength of service.
Gross Profit Margin
Gross profit margin increased in
the period to 44.0% (2023: 42.2%) due to proactive measures taken
by the Group in the areas of SKU rationalisation, customer price
increases, cost mitigation, product re-engineering and
manufacturing efficiency improvements. The Group continues to
benefit from the systems and processes implemented previously to
monitor Cost Price Increases (C.P.I's) across all categories of
supply. These included but were not limited to, plastics, raw
materials, energy, wage inflation and transport (global and
domestic) costs.
Overheads
Distribution costs have decreased
by 25.3% to £1.4m (2023: £1.9m) and now represent 5.2% of sales
(2023: 6.8%).
This is primarily as a result of
the decision to exit the majority of third-party logistics
providers and bringing picking and packing of finished goods in
house. The underlying costs associated with outsourcing the warehousing
and third-party storage have decreased by £0.3m to £0.1m (2023:
£0.4m). A phased approach was undertaken to
ensure consistency of supply and service levels with the majority
of the savings being realised in the second half of the previous
financial year. This has had a positive impact on both costs and
the efficiencies of the business going forward.
Administration costs have decreased
by 4.8% to £8.8m (2023: £9.3m). The
reduction in costs have largely been driven by a combination of
cost rationalisation to align overheads with the reduced business
activity. A decision made to fully integrate the Emma Hardie
business within the Group's operations and facilities has
significantly reduced overheads attributable to the subsidiary by
£0.4m. Investment in the brand, particular consultant costs and
trading partner costs have been curtailed to allow the Group to
re-evaluate its strategy for the brand.
Operating profit before exceptional costs
Operating profit before
exceptional costs was £1.7m (2023: £0.5m), which represents an
increase of £1.2m. Strategic sales price
increases that balanced competitiveness with profitability have
positively impacted the operating profit margin despite the
marginal decline in revenue. Additionally, the Group has been efficient in the management of its
operating costs relative to its revenue. As a result, a greater
percentage of revenue is translated into profit after covering
operating expenses. Operating profit margin before exceptional
costs increased to 6.3% (2023: 1.8%).
Tax
The tax charge provided in the
accounts is £0.47m (2023: £0.02m).
Earnings per share
The diluted earnings per share in
the six-month period was 1.61p (2023: 0.37p).
Cash on hand
Net cash on hand (cash and cash
equivalents less short-term element of obligations under finance
leases and borrowings) is positive £1.5m (2023: negative £1.7m).
The improvement in cash of £3.2m, is mainly attributable to
continued improvements in profit from operations and after paying
dividends of £0.31m.
Stock
Stock has reduced by £1.7m to £8.7m
(2023: £10.4m) in the period. This was achieved by a targeted
reduction in purchasing quantities and manufacturing batch sizes to
reduce stock holding on both raw materials and finished goods. The
reduction in stock levels was a key factor in enabling the transfer
of finished goods from third-party warehousing to the main site in
Peterborough.
Net gearing
With the increase in cash
generation and reduction in cash outflow the business was able to
utilise the cash generated to improve its liquidity by reducing its
reliance on short term borrowings. Additionally, the Group has
reduced its gearing by making an overpayment in March 2024 and
August 2024 to pay down the full balance of the term loan
outstanding at the year end. The Net gearing of 5.2% (2023: 21.4%)
has decreased by 16.2% in the year.
Dividend Payments
The Board does not propose an
interim dividend (2023: Nil).
A final dividend for the year ended
31 March 2024 of 0.45 pence per ordinary share (2023: nil) was paid
on 2 September 2024. The Group had exhibited strong operational
performance and generated cash which in turn has improved the
Group's liquidity and reduced its gearing. This is consistent with
the Directors' objective to align future dividend payments to the
future underlying earnings and cash requirements of the business.
The total dividend paid in the period ended 30 September 2024 was
£0.3m (2023: nil).
Responsibility statement
The names and functions of the
Directors of the Company are as follows:
Paul
Forster
Non-Executive Chairman
Philippa
Clark
Group Managing Director
Martin
Stevens
Deputy Group Managing Director
William O
McIlroy
Non-Executive Director
William T
Glencross
Non-Executive
Director
Nicholas DJ
O'Shea
Non-Executive Director
Brian Geary
Non-Executive Director
The Board confirms that to the
best of its knowledge the condensed set of financial statements
gives a true and fair view of the assets and liabilities, financial
position and profit of the Group and has been prepared in
accordance with IAS 34 'Interim Financial Reporting', as endorsed
by the UK and that the interim management report includes a fair
review of the information required by the Disclosure and
Transparency Rules as issued by the Financial Conduct Authority,
namely:
·
DTR 4.2.7: An indication of important events
that have occurred during the first six months of the financial
year, and their impact on the condensed set of financial
statements, and a description of the principal risks and
uncertainties for the remaining six months of the financial
year.
·
DTR 4.2.8: Details of related party
transactions that have taken place in the first six months of the
current financial year and that have materially affected the
financial position or performance of the enterprise during that
period. Together with any changes in the related party transactions
described in the last annual report that could have a material
effect on the enterprise in the first six months of the current
financial year.
Going Concern
The Directors are pleased to
report that the Group has renewed its bank facilities and continues
to meet its debt obligations and expects to operate comfortably
within its available borrowing facilities. The Group's cash on hand
at 27 November 2024 is positive
£1.0m. As at 31 March 2024 the Group carried out a
review of our cash requirements for the next 12 months. Scenarios
modelled included the removal of the Group's largest customer and
increases of 20% in costs of raw materials or overheads. These
models are more extreme than the conditions prevailing during the
last 12 months but demonstrate that even without management
tackling current overhead levels or increasing prices to customers,
the Group would not fully utilise available bank facilities over
the next 12 months. The Directors have therefore formed a
judgement, at the time of approving the financial statements, that
there is a reasonable expectation that the Group has adequate
resources to continue in operational existence for the foreseeable
future being at least twelve months from the date of this report.
For this reason, the Directors continue to adopt the going concern
basis in preparing the financial statements.
By order of the Board
Paul Forster
Non-Executive
Chairman
27 November 2024
Principal risks and uncertainties
The Board regularly monitors
exposure to key risks, such as those related to production
efficiencies, cash position and competitive position relating to
sales. It has also taken account of the economic situation over the
past 6 months, and the impact that has had on costs and consumer
purchases.
It also monitors those risks not
directly or specifically financial, but capable of having a major
impact on the business's financial performance if there is any
failure, such as product contamination and manufacture outside
specification, maintenance of satisfactory levels of customer and
consumer service, accident ratios, failure to meet environmental
protection standards or any of the areas of regulation mentioned
above.
The principal risks and
uncertainties and their associated mitigating and monitoring
controls which may affect the Group's performance in the next six
months are consistent with those detailed in the Annual Report and
Financial Statements 2024. The main risk facing the Group relates
to the inflationary pressures and weak economic environment. These
are covered in detail in the Managing Director's
statement.
Creightons
plc
Unaudited interim financial
report
for the six months ended 30
September 2024
Consolidated income statement -
unaudited
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended
31 March
2024
(Audited)
|
|
Note
|
£000
|
£000
|
£000
|
Revenue
|
|
27,078
|
27,555
|
53,194
|
Cost of sales
|
|
(15,166)
|
(15,923)
|
(30,364)
|
|
|
|
|
|
Gross profit
|
|
11,912
|
11,632
|
22,830
|
|
|
|
|
|
Distribution costs
|
|
(1,400)
|
(1,874)
|
(3,488)
|
Administrative expenses
|
|
(8,812)
|
(9,252)
|
(17,804)
|
|
|
|
|
|
Operating profit before exceptional
items
|
|
1,700
|
506
|
1,538
|
|
|
|
|
|
Exceptional items - Redundancy
costs
|
7
|
-
|
-
|
(17)
|
|
|
|
|
|
Exceptional items -
Impairment
|
7
|
-
|
-
|
(4,449)
|
|
|
|
|
|
Operating profit
|
|
1,700
|
506
|
(2,928)
|
|
|
|
|
|
Other income - RDEC
income
|
8
|
69
|
-
|
-
|
|
|
|
|
|
Finance costs
|
6
|
(88)
|
(204)
|
(349)
|
|
|
|
|
|
Profit / (Loss) before
tax
|
|
1,681
|
302
|
(3,277)
|
|
|
|
|
|
Taxation
|
4
|
(464)
|
(17)
|
(250)
|
|
|
|
|
|
Profit / (Loss) for the period from
operations attributable to the equity shareholders of the parent
Company
|
|
1,217
|
285
|
(3,527)
|
Consolidated statement of comprehensive income -
unaudited
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended
31 March
2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
Profit / (Loss) for the
period
|
|
1,217
|
285
|
(3,527)
|
|
|
|
|
|
Items that may be
subsequently reclassified to profit and
loss:
|
|
|
|
|
Exchange differences on translating
foreign operations
|
|
(9)
|
8
|
13
|
|
|
|
|
|
Other comprehensive income / (Loss)
for the period
|
|
(9)
|
8
|
13
|
|
|
|
|
|
Total comprehensive income / (Loss)
for the period attributable to the equity shareholders of the
parent
|
|
1,208
|
293
|
(3,514)
|
Dividends
|
Note
|
Six months ended 30
September 2024
(Unaudited)
|
Six months ended 30
September 2023
(Unaudited)
|
Year ended 31 March 2024
(Audited)
|
|
|
|
|
|
Paid in period (£000)
|
|
314
|
-
|
-
|
Paid in period (pence per
share)
|
|
0.45
|
-
|
-
|
Proposed (£000)
|
|
-
|
-
|
314
|
Proposed (pence per
share)
|
|
-
|
-
|
0.45
|
Earnings per share
|
|
Six months ended 30
September 2024
(Unaudited)
|
Six months ended 30
September 2023
(Unaudited)
|
Year ended 31 March 2024
(Audited)
|
|
Note
|
|
|
|
Basic
|
3
|
1.78p
|
0.42p
|
(5.15p)
|
Diluted *
|
|
1.61p
|
0.37p
|
(5.15p)
|
* For the year ended 31 March 2024, share options are excluded from
the earnings per share calculation due to their anti-dilutive
effect on the loss after tax attributable to equity
holders.
Adjusted Earnings
per share - alternate performance measure
The following calculation of the
basic and diluted earnings per share excluding exceptional items
has been calculated based on adding back the following deductions
from (loss) / profit after tax for the year ended 31 March 2024.
Note there were no exceptional items and thus no adjusted EPS calc
for the interim period required for September 2024 and September
2023:
|
|
Year ended 31 March
2024
|
|
|
(Audited)
|
|
|
£000
|
(Loss) for the period from
operations attributable to the equity shareholders of the parent
Company
|
|
(3,527)
|
Exceptional items -
Impairment
|
|
4,449
|
Exceptional items - Deferred tax
charge not previously recognised
|
|
165
|
Adjusted Earnings excluding
exceptional items
|
|
1,087
|
Adjusted Basic earnings per share -
excluding exceptional items
|
|
1.59p
|
Adjusted Diluted earnings per share
- excluding exceptional items
|
|
1.42p
|
Consolidated balance sheet -
unaudited
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March
2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
Non-current assets
|
|
|
|
|
Goodwill
|
|
1,575
|
2,857
|
1,575
|
Other intangible assets
|
|
6,395
|
10,931
|
6,374
|
Property, plant and
equipment
|
|
4,883
|
5,636
|
5,219
|
Right-of-use assets
|
|
1,374
|
1,281
|
1,093
|
|
|
14,227
|
20,705
|
14,261
|
Current assets
|
|
|
|
|
Inventories
|
|
8,683
|
10,445
|
8,225
|
Trade and other
receivables
|
|
13,777
|
12,474
|
10,518
|
Cash and cash equivalents
|
|
2,254
|
1,681
|
3,138
|
|
|
24,714
|
24,600
|
21,881
|
|
|
|
|
|
Total assets
|
|
38,941
|
45,305
|
36,142
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade and other payables
|
|
10,215
|
9,225
|
8,265
|
Corporation tax payable
|
|
526
|
-
|
105
|
Lease liabilities
|
|
531
|
387
|
351
|
Borrowings
|
|
188
|
3,000
|
620
|
|
|
11,460
|
12,612
|
9,341
|
|
|
|
|
|
Net
current assets
|
|
13,254
|
11,988
|
12,540
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
Deferred tax liability
|
|
1,751
|
2,948
|
1,798
|
Lease liabilities
|
|
732
|
797
|
633
|
Borrowings
|
|
2,006
|
3,031
|
2,315
|
|
|
4,489
|
6,776
|
4,746
|
|
|
|
|
|
Total liabilities
|
|
15,949
|
19,388
|
14,087
|
|
|
|
|
|
Net
assets
|
|
22,992
|
25,917
|
22,055
|
|
|
|
|
|
Equity
|
|
|
|
|
Share capital
|
|
700
|
700
|
700
|
Share premium account
|
|
2,024
|
2,024
|
2,024
|
Merger reserve
|
|
2,476
|
2,476
|
2,476
|
Treasury shares
|
|
(576)
|
(576)
|
(576)
|
Other reserves
|
|
(211)
|
(211)
|
(211)
|
Translation reserve
|
|
18
|
22
|
27
|
Retained earnings
|
|
18,561
|
21,482
|
17,615
|
|
|
|
|
|
Total equity attributable to the equity shareholders of the
parent Company
|
|
22,992
|
25,917
|
22,055
|
Statement of changes in shareholders' equity -
unaudited
|
Share
capital
|
Share premium
account
|
Merger
reserve
|
Treasury
shares
|
Other
reserves
|
Translation
reserve
|
Retained
Earnings
|
Total
equity
|
|
|
|
|
|
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At
1 April 2023
|
700
|
2,022
|
2,476
|
(576)
|
(211)
|
14
|
21,054
|
25,479
|
|
|
Comprehensive income for the period
|
|
|
|
|
|
|
|
|
|
|
Profit for the six-month
period
|
-
|
-
|
-
|
-
|
-
|
-
|
285
|
285
|
|
|
Exchange differences on translation
of foreign operations
|
-
|
-
|
-
|
-
|
-
|
8
|
-
|
8
|
|
|
Total comprehensive income for the six months ended 30
September 2023
|
-
|
-
|
-
|
-
|
-
|
8
|
285
|
293
|
|
|
Contributions by and distributions to
owners
|
|
|
|
|
|
|
|
|
|
|
Exercise of options
|
-
|
2
|
-
|
-
|
-
|
-
|
-
|
2
|
|
|
Share-based payment
charge
|
-
|
-
|
-
|
-
|
-
|
-
|
143
|
143
|
|
|
Total contributions by and distributions to
owners
|
-
|
2
|
-
|
-
|
-
|
-
|
143
|
145
|
|
|
At
30 September 2023
|
700
|
2,024
|
2,476
|
(576)
|
(211)
|
22
|
21,482
|
25,917
|
|
|
Comprehensive income for the period
|
|
|
|
|
|
|
|
|
|
|
Profit for the six-month
period
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,812)
|
(3,812)
|
|
|
Exchange differences on translation
of foreign operations
|
-
|
-
|
-
|
-
|
-
|
5
|
-
|
5
|
|
|
Total comprehensive income for the six months ended 31 March
2024
|
-
|
-
|
-
|
-
|
-
|
5
|
(3,812)
|
(3,807)
|
|
|
Contributions by and distributions to
owners
|
|
|
|
|
|
|
|
|
|
|
Share-based payment
charge
|
-
|
-
|
-
|
-
|
-
|
-
|
(32)
|
(32)
|
|
|
Deferred tax through
Equity
|
-
|
-
|
-
|
-
|
-
|
-
|
(23)
|
(23)
|
|
|
Total contributions by and distributions to
owners
|
-
|
-
|
-
|
-
|
-
|
-
|
(55)
|
(55)
|
|
|
At
31 March 2024
|
700
|
2,024
|
2,476
|
(576)
|
(211)
|
27
|
17,615
|
22,055
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share
capital
|
Share premium
account
|
Merger
reserve
|
Treasury
shares
|
Other
reserves
|
Translation
reserve
|
Retained
Earnings
|
Total
equity
|
|
|
|
|
|
|
|
|
|
At
31 March 2024
|
700
|
2,024
|
2,476
|
(576)
|
(211)
|
27
|
17,615
|
22,055
|
Comprehensive income for the period
|
|
|
|
|
|
|
|
|
Profit for the six-month
period
|
-
|
-
|
-
|
-
|
-
|
-
|
1,217
|
1,217
|
Exchange differences on translation
of foreign operations
|
-
|
-
|
-
|
-
|
-
|
(9)
|
-
|
(9)
|
Total comprehensive income for the six months ended 30
September 2024
|
-
|
-
|
-
|
-
|
-
|
(9)
|
1,217
|
1,208
|
Contributions by and distributions to
owners
|
|
|
|
|
|
|
|
|
Share-based payment
charge
|
-
|
-
|
-
|
-
|
-
|
-
|
23
|
23
|
Deferred tax through
Equity
|
-
|
-
|
-
|
-
|
-
|
-
|
20
|
20
|
Dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
(314)
|
(314)
|
Total contributions by and distributions to
owners
|
-
|
-
|
-
|
-
|
-
|
-
|
(271)
|
(271)
|
At
30 September 2024
|
700
|
2,024
|
2,476
|
(576)
|
(211)
|
18
|
18,561
|
22,992
|
Consolidated cash flow statement -
unaudited
|
Note
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March 2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
Profit from operations including redundancy
costs
|
|
1,769
|
506
|
1,521
|
Adjustments for:
|
|
|
|
|
Depreciation on property, plant and
equipment
|
|
479
|
509
|
992
|
Depreciation on right of use
assets
|
|
211
|
183
|
368
|
Amortisation of intangible
assets
|
|
90
|
160
|
358
|
(Profit)/Loss on disposal of
property, plant and equipment
|
|
(1)
|
(7)
|
59
|
Share based payment
charge
|
|
22
|
143
|
111
|
Other income / RDEC
|
|
(69)
|
-
|
-
|
|
|
2,501
|
1,494
|
3,409
|
|
|
|
|
|
(Increase) / decrease in
inventories
|
|
(458)
|
(217)
|
2,003
|
(Increase) / decrease in trade and
other receivables
|
|
(3,258)
|
259
|
2,215
|
Increase / (decrease) in trade and
other payables
|
|
1,948
|
(611)
|
(1,570)
|
Cash generated from operations
|
|
733
|
925
|
6,057
|
Taxation paid
|
|
-
|
-
|
(30)
|
Net
cash from operating activities
|
|
733
|
925
|
6,027
|
|
|
|
|
|
Investing activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
(152)
|
(251)
|
(321)
|
Purchase of intangible
assets
|
|
(111)
|
(197)
|
(287)
|
Proceeds from sale of
assets
|
|
10
|
-
|
-
|
Net
cash used in investing activities
|
|
(253)
|
(448)
|
(608)
|
|
|
|
|
|
Financing activities
|
|
|
|
|
Proceeds on issue of
shares
|
|
-
|
2
|
2
|
Principal paid on lease
liabilities
|
|
(252)
|
(339)
|
(568)
|
Cancellation of leases
|
|
-
|
-
|
(59)
|
Repayment of invoice financing
facilities
|
5
|
-
|
(454)
|
(1,557)
|
Increase of overdraft
|
5
|
-
|
887
|
-
|
Repayment of amounts
borrowed
|
5
|
(37)
|
-
|
(61)
|
Repayment on term loan
|
5
|
(611)
|
(426)
|
(1,329)
|
Interest paid on term
loan
|
5
|
(18)
|
-
|
(123)
|
Repayment on mortgage loan
facility
|
5
|
(93)
|
(127)
|
(180)
|
Interest paid on mortgage loan
facility
|
5
|
(34)
|
-
|
(72)
|
Interest received on bank
deposit
|
|
4
|
|
|
Dividends paid
|
|
(314)
|
-
|
-
|
Net
cash used in financing activities
|
|
(1,355)
|
(457)
|
(3,947)
|
|
|
|
|
|
Net
movement in cash and cash equivalents
|
|
(875)
|
20
|
1,472
|
|
|
|
|
|
Cash and cash equivalents at start
of period
|
|
3,138
|
1,653
|
1,653
|
Effect of foreign exchange rate
changes
|
|
(9)
|
8
|
13
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
2,254
|
1,681
|
3,138
|
Creightons
plc
Unaudited interim financial
report
for the six months ended 30
September 2024
Notes to the unaudited interim financial
report
1. Basis of preparation
The interim financial statements
for the six months ended 30 September 2024 do not constitute
statutory accounts for the purposes of Section 434 of the Companies
Act 2006. The Annual Report and Financial Statements for the year
ended 31 March 2024 have been filed with the Registrar of
Companies. The Independent Auditors' Report on the Annual Report
and Financial Statements for the year ended 31 March 2024 was
unqualified, did not draw attention to any matters by way of
emphasis, and did not contain a statement under sections 498(2) or
498(3) of the Companies Act 2006. The 30 September 2024 statements
were approved by the Board of Directors on 26 November 2024.
This unaudited interim report has not been
audited or reviewed by auditors pursuant to the Financial Reporting
Council guidance on Review of Interim Financial
Information.
The condensed financial statements
in this Interim Report have been prepared in accordance with the
requirements of IAS 34 'Interim Financial Reporting' as endorsed by
the UK.
As required by the Disclosure and
Transparency Rules of the UK's Financial Conduct Authority, the
condensed set of financial statements has been prepared by applying
the accounting policies and presentation that were applied in the
preparation on the Company's published consolidated financial
statements for the year ended 31 March 2024, which were prepared in
accordance with the UK-adopted international accounting
standards.
The condensed interim financial
statements for the six months ended 30 September 2024 and the
comparative figures for the six months ended 30 September 2023 are
unaudited. The figures for the year ended 31 March 2024 have been
extracted from the Annual Report on which the Auditors issued an
unqualified audit report and which have been filed with the
Registrar of Companies.
2. Significant accounting policies
Adoption of new and revised accounting
standards
No new standards impacting on the
Group have been adopted in its financial statements for the year
ended 31 March 2024 or the interims ended 30 September
2024.
There are a number of standards,
amendments to standards, and interpretations which have been issued
by the IASB that are effective in future accounting periods that
the Group has decided not to adopt early. The Group does not expect
any of the standards issued by the IASB, but not yet effective, to
have a material impact on the Group.
3. Earnings per share -
Unaudited
The calculation of the basic and
diluted earnings per share is based on the following
data:
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March 2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
Earnings
|
|
|
|
|
Net profit attributable to the
equity holders of the parent company
|
|
1,217
|
285
|
(3,527)
|
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March 2024
(Audited)
|
|
|
|
|
Number
|
Number
|
Number
|
|
|
Number of shares
|
|
|
|
|
|
|
Weighted average number of ordinary
shares for the purposes of basic earnings per share
|
|
68,435,383
|
68,430,950
|
68,433,858
|
|
|
|
|
|
|
|
|
|
|
|
Effect of dilutive potential
ordinary shares relating to share options
|
|
7,128,857
|
9,141,557
|
8,310,548
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary
shares for the purposes of diluted earnings per share
|
|
75,564,240
|
77,572,507
|
76,744,406
|
|
|
Basic
|
|
1.78p
|
0.42p
|
(5.15p)
|
Diluted
|
|
1.61p
|
0.37p
|
(5.15p)
|
4. Taxation - Unaudited
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March 2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
|
|
|
|
|
Current tax
|
|
499
|
(11)
|
135
|
Deferred tax liability
|
|
(35)
|
28
|
115
|
|
|
|
|
|
Total
|
|
464
|
17
|
250
|
5. Notes to cash flow statement -
Unaudited
Analysis of changes in net debt
6
months ended 30 September 2024
|
Overdraft
|
Invoice
Financing
|
Mortgage
|
Loan
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
At 1 April 2024
|
37
|
-
|
2,287
|
611
|
2,935
|
Cash flows
|
(37)
|
-
|
(93)
|
(611)
|
(741)
|
Cash outflow - interest
|
-
|
-
|
(34)
|
(18)
|
(52)
|
Interest accruing
|
-
|
-
|
34
|
18
|
52
|
|
|
|
|
|
|
At
30 September 2024
|
-
|
-
|
2,194
|
-
|
2,194
|
|
|
|
|
|
|
6
months ended 30 September 2023
|
Overdraft
|
Invoice
Financing
|
Mortgage
|
Loan
|
Total
|
|
£000
|
£000
|
£000
|
£000
|
£000
|
|
|
|
|
|
|
At 1 April 2023
|
26
|
1,557
|
2,467
|
1,940
|
5,990
|
Cash flows
|
887
|
(454)
|
(127)
|
(426)
|
(120)
|
Interest
|
61
|
-
|
37
|
63
|
161
|
|
|
|
|
|
|
At
30 September 2023
|
974
|
1,103
|
2,377
|
1,577
|
6,031
|
|
|
|
|
|
|
12
months ended 31 March 2024
(Audited)
|
Overdraft
|
Invoice
Financing
|
Mortgage
|
Loan
|
Total
|
|
£000
|
£000
|
£000
|
|
£000
|
|
|
|
|
|
|
At 1 April 2023
|
26
|
1,557
|
2,467
|
1,940
|
5,990
|
Cash flows
|
(61)
|
(1,557)
|
(180)
|
(1,329)
|
(3,127)
|
Cash outflow - interest
|
-
|
-
|
(72)
|
(123)
|
(195)
|
Interest accruing
|
72
|
-
|
72
|
123
|
267
|
|
|
|
|
|
|
At
31 March 2024
|
37
|
-
|
2,287
|
611
|
2,935
|
6. Finance costs - Unaudited
|
|
Six months ended 30
September 2024
|
Six months ended 30
September 2023
|
Year ended 31 March 2024
(Audited)
|
|
|
£000
|
£000
|
£000
|
|
|
|
|
|
Interest on bank overdrafts and
loans
|
|
18
|
124
|
195
|
Interest on mortgage
|
|
34
|
37
|
72
|
Interest on lease
liabilities
|
|
40
|
43
|
86
|
Other interest
|
|
(4)
|
-
|
(4)
|
Total
|
|
88
|
204
|
349
|
7. Exceptional items
Redundancy costs in year ended 31 March 2024
Redundancy costs of £0.02m have
been incurred in the year to March 2024.
Impairment of Emma Hardie brand value in year ended 31 March
2024
As required by IAS 36, the Group
reassesses its capitalised intangible assets for impairment on an
annual basis. Following the difficult trading years of the Emma
Hardie subsidiary, management have assessed that the brand value
acquired on acquisition in relation to Emma Hardie has been
impaired by £4.4m. This is shown as a separate line item in the
Consolidated profit and loss account as it is an expense that is
not in line with the normal trading operations of the Group. The
impact of this impairment was not cash impacting and was an entry
that reduces the intangible assets (Brand value for Emma Hardie) on
the balance sheet with a corresponding entry in the Consolidated
income statement. The associated goodwill and deferred tax
liability were derecognised from the balance sheet. Please refer to
notes 3, 8, 13 and note 14 of the full accounts to 31 March
2024.
8. Updated SME R&D Relief Scheme: For
accounting periods beginning on or after 01 April
2024
The UK Government's recent overhaul
of the R&D tax relief system has resulted in a merged "single"
Research and Development Expenditure Credit (RDEC) Scheme which
provides a headline credit rate of 20%. This credit will now be
recognised as "other income" and is taxable, leading to a net
benefit 15% of qualifying R&D expenditure. The Group pays the
main corporation tax rate of 25%.
9. Related party transactions
The related party transactions that
occurred in the six months ended 30 September 2024 are not
materially different in size or nature to those reported in the
Company's Annual Report for the year ended 31 March
2024.
10. Availability of Interim Report
The Interim Report is being made
available to shareholders on the Company website
www.creightonsplc.com. Further copies can be obtained from the
Company's Registered Office, 1210 Lincoln Road, Peterborough, PE4
6ND.
For more information:
Pippa Clark, Director, Creightons
plc 01733
281058
Roland Cornish, Beaumont Cornish
Limited
0207
628 3396
Beaumont Cornish Limited, which is
authorised and regulated in the United Kingdom by the Financial
Conduct Authority, is Financial Adviser to the Company in relation
to the matters referred herein. Beaumont Cornish Limited is acting
exclusively for the Company and for no one else in relation to the
matters described in this announcement and is not advising any
other person and accordingly will not be responsible to anyone
other than the Company for providing the protections afforded to
clients of Beaumont Cornish Limited, or for providing advice in
relation to the contents of this announcement or any matter
referred to in it.